| 04/30/2026 3:17 PM | Kezar Life Sciences (1645666) Filer | Form 10-K/A | |
| 04/14/2026 5:01 AM | Kezar Life Sciences (1645666) Subject | Form SC 14D9 | |
| 04/13/2026 6:27 AM | Aurinia Pharmaceuticals Inc. (1600620) Filed by Kezar Life Sciences (1645666) Subject | Form SC TO-T | |
| 04/06/2026 8:28 PM | Baselake Partners, LP (1957912) Filed by Kezar Life Sciences (1645666) Subject | Form SCHEDULE 13G | |
| 04/03/2026 3:58 PM | Kezar Life Sciences (1645666) Subject | Form SC14D9C | |
| 04/03/2026 3:49 PM | Kezar Life Sciences (1645666) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/03/2026 3:49 PM | Kezar Life Sciences (1645666) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/30/2026 7:32 AM | Kezar Life Sciences (1645666) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/30/2026 7:36 AM | Kezar Life Sciences (1645666) Subject | Form SC14D9C | |
| 03/27/2026 3:15 PM | Kezar Life Sciences (1645666) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/12/2026 8:11 AM | Kezar Life Sciences (1645666) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/09/2026 1:39 PM | BML Investment Partners, L.P. (1373604) Filed by Kezar Life Sciences (1645666) Subject | Form SCHEDULE 13G/A | |
| 11/14/2025 12:33 PM | Avidity Partners Management LP (1791827) Filed by Kezar Life Sciences (1645666) Subject | Form SCHEDULE 13G/A | |
| 11/12/2025 3:07 PM | Kezar Life Sciences (1645666) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/07/2025 3:21 PM | Kezar Life Sciences (1645666) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2025 3:19 PM | Kezar Life Sciences (1645666) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/16/2025 3:22 PM | Kezar Life Sciences (1645666) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/08/2025 4:44 PM | Kezar Life Sciences (1645666) Subject Stonepine Capital Management, LLC (1440771) Filed by | Form SCHEDULE 13G | |
| 07/03/2025 3:15 PM | Kezar Life Sciences (1645666) Issuer Schiller Mark C. (2007659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/03/2025 3:15 PM | Chiang Pichi Luo (2064744) Reporting Kezar Life Sciences (1645666) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2025 4:25 PM | Kezar Life Sciences (1645666) Issuer To Zung Phuong (2064777) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2025 3:06 PM | Kezar Life Sciences (1645666) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |